JAMA Neurology—The Year in Review, 2020

The last 12 months have been unprecedented here at JAMA Neurology. In the setting of the coronavirus disease 2019 (COVID-19) pandemic, the journal had to rapidly evolve to handle a record number of manuscripts and respond to the needs of our readers to be informed of the most timely and important neurological information about the virus. We received more than 400 submissions related to COVID-19, and we were able to publish very quickly those select contributions that we felt truly were important for neurologists on the frontlines, including the initial experience of neurological complications from Wuhan province, China, and important observations on the pathobiology of nervous system involvement.